Franz Obermayr

Title: Franz Obermayr: Innovator in Cancer Treatment

Introduction

Franz Obermayr is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on combining various therapeutic agents to enhance treatment efficacy.

Latest Patents

Obermayr holds a patent for an "Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and EGFR inhibitors or pyrimidine analogues." This invention describes methods and compositions for the prevention and treatment of cancer or tumors. It specifically addresses a combination therapy that includes inhibitors of the EGFR family or chemotherapeutically active pyrimidine analogues alongside platinum-based chemotherapeutic agents.

Career Highlights

Throughout his career, Obermayr has been dedicated to advancing cancer therapies. His innovative approach has led to the development of effective treatment methods that aim to improve patient outcomes. He is currently associated with Agennix AG, a company focused on developing novel cancer therapies.

Collaborations

Obermayr has collaborated with several professionals in the field, including Katja Wosikowski-Buters and Christoph Schaab. These collaborations have contributed to the advancement of his research and the successful development of his patented therapies.

Conclusion

Franz Obermayr's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving therapeutic options for patients. His work continues to influence the field of oncology and offers hope for more effective cancer treatments in the future.